CENTRE HOSPITALIER UNIV BORDEAUX has a total of 27 patent applications. It decreased the IP activity by 72.0%. Its first patent ever was published in 2008. It filed its patents most often in Australia, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are NANJING DRUM TOWER HOSPITAL, UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION and AL KON RISERCH LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | Brazil | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | United States | 3 | |
#6 | France | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Diagnosis and surgery | |
#5 | Analysing materials | |
#6 | Syringes | |
#7 | Microorganisms | |
#8 | Object sterilising | |
#9 | Peptides | |
#10 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dumas De La Roque Eric | 5 |
#2 | Cornelis François | 5 |
#3 | Cornelis Francois | 3 |
#4 | Thambo Jean-Benoit | 2 |
#5 | Diolez Philippe | 2 |
#6 | Cochet Hubert | 2 |
#7 | Frédéric Marin | 2 |
#8 | Taieb Alain | 2 |
#9 | Petitjean Olivier | 2 |
#10 | Leaute-Labreze Christine | 2 |
Publication | Filing date | Title |
---|---|---|
AU2018265591A1 | Method of segmentation of a three-dimensional image for generating a model of a myocardial wall for the detection of at least one singular zone of electrical circulation | |
BR112019012253A2 | mmp9 inhibitors and their uses in the prevention or treatment of a depigmentation disorder | |
EP3525860A1 | Mask for artificial ventilation of a patient | |
WO2018020150A1 | Intraosseous stent | |
EP3300733A1 | Substance selected among irinotecan, an irinotecan active metabolite, 5-fluoro-uracile, a pharmaceutical salt thereof and a mixture thereof, for use in the treatment of fibrosis | |
AU2016319184A1 | Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production | |
BR112018004518A2 | compounds for the treatment of diseases linked to the production of reactive mitochondrial oxygen species (ros) | |
FR3050925A1 | Intra-bone injection system for surgical cement | |
AU2015254675A1 | Method for quantifying the presence of fats in a region of the heart | |
AU2014201660A1 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |